Biomedical research
IP at World Health Assembly Private monopolies hinder progress on public health: intellectual property at the 75th World Health Assembly

Obstruction by pharmaceutical companies from the Global North and misuse of monopoly privileges continue to slow down research into new vaccines and medicines, with disastrous effects for people’s health in the Global South. Discussions at the 75th World Health Assembly did little to address this